Meningococcal polysaccharide vaccine group A

Identification

Brand Names

Menquadfi, Menveo, Nimenrix

Generic Name

Meningococcal polysaccharide vaccine group A

DrugBank Accession Number

DB13889

Background

Meningococcal group A polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup A. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup A.

Type

Biotech

Groups

Approved, Experimental, Investigational

Biologic Classification

Vaccines
Other vaccines

Synonyms

• Meningococcal group A polysaccharide
• Meningococcal polysaccharide antigen group A
• Neisseria meningitidis group A capsular polysaccharide antigen
• Neisseria meningitidis group A polysaccharide antigen, A

Pharmacology

Indication

Not Available

Reduce drug development failure rates

Build, train, & validate machine-learning models
with evidence-based and structured datasets.

See how

Build, train, & validate predictive machine-learning models with structured datasets.

See how

Associated Conditions

• Invasive Meningococcal Infection caused by Neisseria meningitidis serogroup A

Contraindications & Blackbox Warnings

Avoid life-threatening adverse drug events

Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.

Learn more

Avoid life-threatening adverse drug events & improve clinical decision support.

Learn more

Pharmacodynamics

Not Available

Mechanism of action

Not Available

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Not Available

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects

Improve decision support & research outcomes

With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.

Learn more

Improve decision support & research outcomes with our structured adverse effects data.

Learn more

Toxicity

Not Available

Pathways

Not Available

Pharmacogenomic Effects/ADRs

Not Available

Interactions

Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Not Available

Food Interactions

Not Available

Products

Drug product information from 10+ global regions

Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.

Access now

Access drug product information from over 10 global regions.

Access now

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End	Region	Image
MENACTRA 0,5 ML IM ENJEKSİYONLUK ÇÖZELTİ İÇEREN FLAKON, 1 ADET	Meningococcal polysaccharide vaccine group A (4 mcg/0.5ml) + Meningococcal polysaccharide vaccine group C (4 mcg/0.5ml) + Meningococcal polysaccharide vaccine group W-135 (4 mcg/0.5ml) + Meningococcal polysaccharide vaccine group Y (4 mcg/0.5ml)	Injection, solution	Intramuscular	SANOFİ PASTEUR AŞI TİC. A.Ş.	2020-08-14	Not applicable
MENACTRA 0,5 ML IM ENJEKSİYONLUK ÇÖZELTİ İÇEREN FLAKON, 5 ADET	Meningococcal polysaccharide vaccine group A (4 mcg/0.5ml) + Meningococcal polysaccharide vaccine group C (4 mcg/0.5ml) + Meningococcal polysaccharide vaccine group W-135 (4 mcg/0.5ml) + Meningococcal polysaccharide vaccine group Y (4 mcg/0.5ml)	Injection, solution	Intramuscular	SANOFİ PASTEUR AŞI TİC. A.Ş.	2020-08-14	Not applicable
Mencevax Ac Pws 500mcg/vial	Meningococcal polysaccharide vaccine group A (500 mcg / vial) + Meningococcal polysaccharide vaccine group C (500 mcg / vial) + Sodium chloride (5 mL / vial)	Powder, for solution	Subcutaneous	Glaxosmithkline Inc	1994-08-29	2006-06-02
Mencevax Ac Pws 50mcg/vial	Meningococcal polysaccharide vaccine group A (50 mcg / vial) + Meningococcal polysaccharide vaccine group C (50 mcg / vial) + Sodium chloride (.5 mL / vial)	Powder, for solution	Subcutaneous	Glaxosmithkline Inc	1992-12-31	2006-06-02
Mencevax Ac Pws Inj 2500mcg/vial	Meningococcal polysaccharide vaccine group A (2.5 mg / vial) + Meningococcal polysaccharide vaccine group C (2.5 mg / vial) + Sodium chloride (25 mL / vial)	Powder, for solution	Subcutaneous	Glaxosmithkline Inc	1992-12-31	2006-06-02
MENCEVAX ACWY 0,5 ML SC ENJEKSİYON İÇİN LİYOFİLİZE TOZ İÇEREN ÇOK DOZLU FLAKON, 50 ADET	Meningococcal polysaccharide vaccine group A (50 mcg/0.5ml) + Meningococcal polysaccharide vaccine group C (50 mcg/0.5ml) + Meningococcal polysaccharide vaccine group W-135 (50 mcg/0.5ml) + Meningococcal polysaccharide vaccine group Y (50 mcg/0.5ml)	Injection, powder, for solution	Subcutaneous	PFİZER PFE İLAÇLARI A.Ş.	2020-08-14	2019-07-01
Meningococcal Polysaccharide Vaccine Groups A & C	Meningococcal polysaccharide vaccine group A (500 mcg / vial) + Meningococcal polysaccharide vaccine group C (500 mcg / vial)	Kit; Powder, for solution	Subcutaneous	Aventis Pasteur Sa	1998-08-13	2007-08-14
Menomune - A/c/y/w-135 Combined	Meningococcal polysaccharide vaccine group A (50 ug/0.5mL) + Meningococcal polysaccharide vaccine group C (50 ug/0.5mL) + Meningococcal polysaccharide vaccine group W-135 (50 ug/0.5mL) + Meningococcal polysaccharide vaccine group Y (50 ug/0.5mL)	Injection; Kit	Subcutaneous	Sanofi Pasteur Inc.	1981-11-23	2017-09-10
Menomune-A/c/y/w-135	Meningococcal polysaccharide vaccine group A (50 mcg / 0.5 mL) + Meningococcal polysaccharide vaccine group C (50 mcg / 0.5 mL) + Meningococcal polysaccharide vaccine group W-135 (50 mcg / 0.5 mL) + Meningococcal polysaccharide vaccine group Y (50 mcg / 0.5 mL)	Kit; Powder, for solution	Subcutaneous	Sanofi Pasteur Limited	1993-10-29	2017-04-05
Menomune-A/c/y/w-135	Meningococcal polysaccharide vaccine group A (500 mcg / kit) + Meningococcal polysaccharide vaccine group C (500 mcg / kit) + Meningococcal polysaccharide vaccine group W-135 (500 mcg / kit) + Meningococcal polysaccharide vaccine group Y (500 mcg / kit)	Powder, for solution	Subcutaneous	Sanofi Pasteur Limited	1983-12-31	2017-04-05

Categories

Drug Categories

• Actively Acquired Immunity
• Antigens
• Antigens, Bacterial
• Biological Factors
• Carbohydrates
• Inactivated Meningococcal Vaccine
• Polysaccharides

Classification

Not classified

Affected organisms

Not Available

Chemical Identifiers

UNII

1I86B47NY4

CAS number

Not Available

References

General References

Not Available

External Links

PubChem Substance

347911458

RxNav

29501

FDA label

Download (83.9 KB)

Clinical Trials

Clinical Trials

Phase	Status	Purpose	Conditions	Count
4	Active Not Recruiting	Prevention	Papilloma Viral Infection	1
4	Completed	Basic Science	Meningitis / Meningococcal Disease / Septicemia	1
4	Completed	Prevention	Meningococcal Disease	1
4	Completed	Prevention	Meningococcal Disease, Invasive	1
4	Completed	Treatment	Immunizations / Meningitis / Pertussis / Preventive Immunization; Meningitis	1
4	Recruiting	Prevention	Human Immunodeficiency Virus (HIV) Infections / Meningococcal Infections / Pneumococcal Infection	1
3	Active Not Recruiting	Prevention	Meningitis	1
3	Active Not Recruiting	Prevention	Meningococcal Infections	1
3	Completed	Prevention	Bacterial Infections / Neisseria Meningitidis / Viral Disease	1
3	Completed	Prevention	Meningitis / Meningococcal Infections / Meningococcal Meningitis	1

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Form	Route	Strength
Injection, solution	Intramuscular
Powder, for solution	Subcutaneous
Injection, powder, for solution	Subcutaneous
Kit; powder, for solution	Subcutaneous
Injection; kit	Subcutaneous
Powder	Intramuscular
Powder, for solution; solution	Intramuscular
Injection, powder, lyophilized, for solution	Intramuscular
Injection, powder, for solution	Intramuscular
Injection, powder, for solution	Intramuscular	10 mcg/0.5ml
Kit; powder, for solution	Intramuscular
Injection, powder, for solution

Prices

Not Available

Patents

Not Available

Properties

State

Not Available

Experimental Properties

Not Available

×

Identify potential medication risks

Easily compare up to 40 drugs with our drug interaction checker.

Get severity rating, description, and management advice.

Learn more

Drug created at September 08, 2017 20:22 / Updated at June 12, 2020 16:53